Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Idetrexed |
| Synonyms | |
| Therapy Description |
Idetrexed (BGC-945) is a thymidylate synthase inhibitor that binds to Folr1 and is internalized via endocytosis, leading to decreased growth of Folr1-expressing cells (PMID: 16357184, PMID: 23710599). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Idetrexed | ONX-0801|ONX0801|ONX 0801|BGC 945|BGC945|BGC-945 | FOLR1-targeted Therapy 24 | Idetrexed (BGC-945) is a thymidylate synthase inhibitor that binds to Folr1 and is internalized via endocytosis, leading to decreased growth of Folr1-expressing cells (PMID: 16357184, PMID: 23710599). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|